A Single Group Study to Evaluate the Effects of a Probiotic Supplement on Vaginal Health.

Love Wellness40 enrolled

Overview

This virtual single-group clinical trial aims to evaluate the effects of the Good Girl Probiotics supplement on vaginal health. Participants will take one capsule of the probiotic supplement daily for eight weeks. They will complete questionnaires at Baseline, after the first dose, and at the end of Weeks 2, 4, 6, and 8 to assess changes in vaginal pH, vaginal health, and urinary tract health.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Vaginal Health Women's Health

Interventions

Good Girl ProbioticsDIETARY_SUPPLEMENT

Participants will take one capsule of the Good Girl Probiotics supplement daily in the morning for eight weeks.

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Female at birth. * Aged 18+. * Interested in supporting a balanced vaginal pH, vaginal health, and urinary tract health. * Regularly experience symptoms of an unbalanced vagina, including an atypical smell, discharge, itching, swelling, irritation, pain during sex, and/or burning sensation while urinating. * Willing to avoid using products or medications that target vaginal or urinary tract health infections. * Willing to avoid other probiotics. * Able to follow the study protocol. Exclusion Criteria: * Two or more bladder infections in six months or three or more infections in a year. * Recent surgeries or invasive treatments within the last six months. * Use of products or medications targeting vaginal or urinary tract health in the last 12 weeks. * Known allergies to the product ingredients. * Chronic health conditions impacting participation. * Pregnant, breastfeeding, or trying to conceive. * History of substance abuse. * Current or former smoker within the past six months. * Participation in another clinical trial. * Diagnosed vaginal or pelvic conditions. * Use of vaginal-related birth control (NuvaRing, IUD). * Changes in hormonal birth control in the last three months.

Locations (1)

Citruslabs

Santa Monica, California, United States

Outcomes

Primary Outcomes

Vaginal and Urinary Tract Health and Balance

Assessment of vaginal and urinary tract health and balance through questionnaires completed by participants at Baseline, after the first dose, and at the end of Weeks 2, 4, 6, and 8.

Time frame: Baseline, Week 2, Week 4, Week 6, Week 8

Secondary Outcomes

Vaginal Environment and Odor

Assessment of the vaginal environment and odor through questionnaires completed by participants at Baseline, after the first dose, and at the end of Weeks 2, 4, 6, and 8.

Time frame: Baseline, Week 2, Week 4, Week 6, Week 8

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.